Source: Programme & Abstracts. Conference titles: European Conference on Fungal Genetics (ECFG). Unidades: FMRP, FCFRP
Subjects: ARTHRODERMATACEAE (TRATAMENTO), ANTIFÚNGICOS
ABNT
PERES, Nalu T. A. et al. Treatment of Trichophyton rubrum ex vivo skin infection with a new antifungal agent, ambruticin, leads to the activation or repression of several genes, including a putative mitochondrial protein and a subtilisin protease. 2010, Anais.. Leiden: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2010. . Acesso em: 30 ago. 2024.APA
Peres, N. T. A., Gras, D. E., Sanches, P. R., Falcão, J. P., Rocha, L., Mazucato, M., et al. (2010). Treatment of Trichophyton rubrum ex vivo skin infection with a new antifungal agent, ambruticin, leads to the activation or repression of several genes, including a putative mitochondrial protein and a subtilisin protease. In Programme & Abstracts. Leiden: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Peres NTA, Gras DE, Sanches PR, Falcão JP, Rocha L, Mazucato M, Rossi A, Prade RA, Martinez-Rossi NM. Treatment of Trichophyton rubrum ex vivo skin infection with a new antifungal agent, ambruticin, leads to the activation or repression of several genes, including a putative mitochondrial protein and a subtilisin protease. Programme & Abstracts. 2010 ;[citado 2024 ago. 30 ]Vancouver
Peres NTA, Gras DE, Sanches PR, Falcão JP, Rocha L, Mazucato M, Rossi A, Prade RA, Martinez-Rossi NM. Treatment of Trichophyton rubrum ex vivo skin infection with a new antifungal agent, ambruticin, leads to the activation or repression of several genes, including a putative mitochondrial protein and a subtilisin protease. Programme & Abstracts. 2010 ;[citado 2024 ago. 30 ]